Quantitation of cytomegalovirus: Methodologic aspects and clinical applications

Clinical Microbiology Reviews

Volumn 11, Issue 3, 1998, Pages 533-554

  Boeckh, Michael ^a   Boivin, Guy ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; VIRUS ANTIGEN; VIRUS DNA;

CYTOMEGALOVIRUS INFECTION; DNA DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ORGAN TRANSPLANTATION; RECIPIENT; REVIEW; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD;

EID: 0031821865     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.11.3.533     Document Type: Review

References (188)

1. Arribas, J. R., D. B. Clifford, C. J. Fichtenbaum, D. L. Commins, W. G. Powderly, and G. A. Storch. 1995. Level of cytomegalovirus (CMV) DNA in cerebrospinal fluid of subjects with AIDS and CMV infection of the central nervous system. J. Infect. Dis. 172:527-531.
2. Aspin, M. M., G. M. Gallez-Hawkins, T. D. Giugni, B. Tegtmeier, D. J. Lang, G. M. Schmidt, S. J. Forman, and J. A. Zaia. 1994. Comparison of plasma PCR and bronchoalveolar lavage fluid culture for detection of cytomegalovirus infection in adult bone marrow transplant recipients. J. Clin. Microbiol. 32:2266-2269.
3. Autran, B., G. Carcelain, T. S. Li, C. Blanc, D. Mathez, R. Tubiana, C. Katlama, P. Debre, and J. Leibowitch. 1997. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277:112-116.
4. Bacigalupo, A., E. Tedone, M. A. Sanna, F. Moro, M. T. Van Lint, G. Grazi, M. Balestreri, F. Frassoni, D. Occhini, F. Gualandi, et al. 1992. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality. Haematologica 77:507-513.
5. Bacigalupo, A., M. T. van Lint, E. Tedone, F. Moro, M. A. Sanna, M. Longren, G. Trespi, F. Frassoni, D. Occhini, F. Gualandi, et al. 1994. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir. Bone Marrow Transplant. 13:753-758.
6. Bailey, T. C., R. S. Buller, N. A. Ettinger, E. P. Trulock, M. Gaudreault-Keener, T. M. Langlois, J. E. Fornoff, J. D. Cooper, and G. A. Storch. 1995. Quantitative analysis of cytomegalovirus viremia in lung transplant recipients. J. Infect. Dis. 171:1006-1010.
7. Balfour, H. H., C. V. Fletcher, A. Erice, W. K. Henry, E. P. Acosta, S. A. Smith, M. A. Holm, G. Boivin, D. H. Shepp, C. S. Crumpacker, C. A. Eaton, and S. S. Martinmunley. 1996. Effect of foscarnet on quantities of cytomegalovirus and human immunodeficiency virus in blood of persons with AIDS. Antimicrob. Agents Chemother. 40:2721-2726.
8. Bein, G., A. Bitsch, J. Hoyer, and H. Kirchner. 1991. The detection of human cytomegalovirus immediate early antigen in peripheral blood leucocytes. J. Immunol. Methods 137:175-180.
9. Bek, B., M. Boeckh, J. Lepenies, B. Bieniek, K. Arasteh, W. Heise, K. M. Deppermann, G. Bornhoft, M. Stöffler-Meilicke, I. Schuller, and G. Höffken. 1996. High-level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up. J. Clin. Microbiol. 34:457-459.
10. Boeckh, M. Unpublished results.
11. Boeckh, M., B. Bek, J. Lepenies, and G. Höffken. 1996. Interest of quantitative pp65 cytomegalovirus antigenemia assay for human immunodeficiency virus-positive patients. J. Clin. Microbiol. 34:3255-3256. (Reply.)
12. Boeckh, M., R. A. Bowden, J. M. Goodrich, M. Pettinger, and J. D. Meyers. 1992. Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation. Blood 80:1358-1364.
13. Boeckh, M., T. Gooley, D. Myerson, and B. Torok-Storb. 1997. Specific CMV gB genotypes are associated with viremia in patients with CMV disease after allogeneic marrow transplant, abstr. 1508. In 8th European Congress of Clinical Microbiology and Infectious Diseases, Lausanne, Switzerland.
14. Boeckh, M., T. A. Gooley, D. Myerson, T. Cunningham, G. Schoch, and R. A. Bowden. 1996. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 88:4063-4071.
15. Boeckh, M., T. A. Gooley, P. Reusser, C. D. Buckner, and R. A. Bowden. 1995. Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation. J. Infect. Dis. 172:939-943.
16. Boeckh, M., G. Hawkins, D. Myerson, J. Zaia, and R. A. Bowden. 1997. Plasma PCR for cytomegalovirus DNA after allogeneic marrow transplantation: comparison with PCR using peripheral blood leukocytes, pp65 antigenemia, and viral culture. Transplantation 64:108-113.
17. Boeckh, M., D. Myerson, and R. A. Bowden. 1994. Early detection and treatment of cytomegalovirus infections in marrow transplant patients: methodological aspects and implications for therapeutic interventions. Bone Marrow Transplant. 14:S66-S70.
18. Boeckh, M., S. K. Riddell, T. Cunningham, D. Myerson, M. Flowers, and R. A. Bowden. 1996. Increased incidence of late CMV disease in allogeneic marrow transplant recipients after ganciclovir prophylaxis is due to a lack of CMV-specific T cell responses. Blood 88(Suppl. 1):302a.
19. Boeckh, M., T. Stevens-Ayers, and R. A. Bowden. 1996. Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation. J. Infect. Dis. 174:907-912.
20. Boeckh, M., P. M. Woogerd, T. Stevens-Ayers, C. G. Ray, and R. A. Bowden. 1994. Factors influencing detection of quantitative cytomegalovirus antigenemia. J. Clin. Microbiol. 32:832-834.
21. Boivin, G., S. Chou, M. R. Quirk, A. Erice, and M. C. Jordan. 1996. Detection of ganciclovir resistance mutations quantitation of cytomegalovirus (CMV) DNA in leukocytes of patients with fatal disseminated CMV disease. J. Infect. Dis. 173:523-528.
22. Boivin, G., C. Gilbert, M. Morissette, J. Handfield, N. Goyette, and M. G. Bergeron. 1997. A case of ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with AIDS - longitudinal molecular analysis of the CMV viral load and viral mutations in blood compartments. AIDS 11:867-873.
23. Boivin, G., J. Handfield, G. Murray, E. Toma, R. Lalonde, J. G. Lazar, and T. G. Bergeron. 1997. Quantitation of cytomegalovirus (CMV) DNA in leukocytes of human immunodeficiency virus-infected subjects with and without CMV disease by using PCR and the sharp signal detection system. J. Clin. Microbiol. 35:525-526.
24. Boivin, G., J. Handfield, E. Toma, G. Murray, R Lalonde, and M. G. Bergeron. 1998. Comparative evaluation of the cytomegalovirus DNA load in polymorphonuclear leukocytes and plasma of human immunodeficiency virus-infected subjects. J. Infect. Dis. 177:355-360.
25. Boivin, G., C. A. Olson, M. R. Quirk, B. Kringstad, M. I. Hertz, and M. C. Jordan. 1996. Quantitation of cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with and without pneumonitis. J. Infect. Dis. 173:1304-1312.
26. Boivin, G., C. A. Olson, M. R. Quirk, S. M. St. Cyr, and M. C. Jordan. 1995. Quantitation of human cytomegalovirus glycoprotein H gene in cells using competitive PCR and a rapid fluorescence-based detection system. J. Virol. Methods 51:329-342. (Erratum, 53:165, 1995.)
27. Boivin, G., M. R. Quirk, B. A. Kringstad, M. Germain, and M. C. Jordan. 1997. Early effects of ganciclovir therapy on the quantity of cytomegalovirus DNA in leukocytes of immunocompromised patients. Antimicrob. Agents Chemother. 41:860-862.
28. Boland, G. J., W. E. Mesker, R. Doorn, J. J. Ploem-Zaaijer, H. J. Tank, and G. C. de Gast. 1995. Detection improvement of cytomegalovirus antigen in human peripheral blood using monoclonal antibodies and automated reading of cell preparations. Eur. J. Clin. Invest. 25:639-646.
29. Bongarts, A., D. Vonlaer, C. Vogelberg, K. Ebert, J. Vanlunzen, J. Garweg, P. Vaith, F. T. Hufert, O. Haller, and U. Meyerkönig. 1996. Glycoprotein B genotype of human cytomegalovirus - distribution in HIV-infected patients. Scand. J. Infect. Dis. 28:447-449.
30. Bossart, W., K. Bienz, and W. Wunderli. 1997. Surveillance of cytomegalovirus after solid-organ transplantation - comparison of pp65 antigenemia assay with a quantitative DNA hybridization assay. J. Clin. Microbiol. 35: 3303-3304.
31. Bowen, E. F., C. A. Sabin, P. Wilson, P. D. Griffiths, C. C. Davey, M. A. Johnson, and V. C. Emery. 1997. Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. Aids. 11:889-893.
32. Bowen, E. F., P. Wilson, A. Cope, C. Sabin, P. Griffiths, C. Davey, M. Johnson, and V. Emery. 1996. Cytomegalovirus retinitis in AIDS patients: influence of cytomegaloviral load on response to ganciclovir, time to recurrence and survival. AIDS 10:1515-1520.
33. Brytting, M., W. Xu, B. Wahren, and V. A. Sundqvist. 1992. Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J. Clin. Microbiol. 30:1937-1941.
34. Buller, R. S., T. C. Bailey, N. A. Ettinger, M. Keener, T. Langlois, J. P. Miller, and G. A. Storch. 1992. Use of a modified shell vial technique to quantitate cytomegalovirus viremia in a population of solid-organ transplant recipients. J. Clin. Microbiol. 30:2620-2624.
35. Cagle, P. T., G. Buffone, V. A. Holland, T. Samo, G. J. Demmler, G. P. Noon, and E. C. Lawrence. 1992. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification. Chest 101:93-96.
36. Chernoff, D. N., R. C. Miner, B. S. Hoo, L. P. Shen, R. J. Kelso, D. Jekicmcmullen, J. P. Lalezari, S. W. Chou, W. L. Drew, and J. A. Kolberg. 1997. Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. J. Clin. Microbiol. 35:2740-2744.
37. Chou, S. W., and K. M. Scott. 1988. Rapid quantitation of cytomegalovirus and assay of neutralizing antibody by using monoclonal antibody to the major immediate-early viral protein. J. Clin. Microbiol. 26:504-507.
38. Churchill, M. A., J. A. Zaia, S. J. Forman, K. Sheibani, N. Azumi, and K. G. Blume. 1987. Quantitation of human cytomegalovirus DNA in lungs from bone marrow transplant recipients with interstitial pneumonia. J. Infect. Dis. 155:501-509.
39. Clementi, M., S. Menzo, P. Bagnarelli, A. Manzin. A. Valenza, and P. E. Varaldo. 1993. Quantitative PCR and RT-PCR in virology. PCR Methods Appl. 2:191-196.
40. Clementi, M., S. Menzo, P. Bagnarelli, A. Valenza, S. Paolucci, R. Sampaolesi, A. Manzin, and P. E. Varaldo. 1996. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin. Microbiol. Rev. 9:135-147.
41. + T-cell repertoire that are not immediately restored by antiretroviral or immunebase therapy. Nat. Med. 3:533-540.
42. Cope, A. V., C. Sabin, A. Burroughs, K. Rolles, P. D. Griffiths, and V. C. Emery. 1997. Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J. Infect. Dis. 176:1484-1490.
43. Cope, A. V., P. Sweny, C. Sabin, L. Rees, P. D. Griffiths, and V. C. Emery. 1997. Quantity of cytomegalovirus viruria is a major risk factor for cytomegalovirus disease after renal transplantation. J. Med. Virol. 52:200-205.
44. Cotte, L., E. Drouet, F. Bailly, S. Vitozzi, G. A. Denoyel, and C. Trepo. 1996. Cytomegalovirus DNA level on biopsy specimens during treatment of cytomegalovirus gastrointestinal disease. Gastroenterology 111:439-444.
45. Dodt, K. K., P. H. Jacobsen, B. Hofmann, C. Meyer, H. J. Kolmos, P. Skinhoj, B. Norrild, and L. Mathiesen. 1997. Development of cytomegalovirus (CMV) disease may be predicted in HIV-infected patients by CMV polymerase chain reaction and the antigenemia test. AIDS 11:F21-F28.
46. Drew, W. L., R. C. Miner, D. F. Busch, S. E. Follansbee, J. Gullett, S. G. Mehalko, S. M. Gordon, W. F. Owen, Jr., T. R. Matthews, W. C. Buhles, et al. 1991. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J. Infect. Dis. 163:716-719.
47. Ehrnst, A., and H. Einsele. 1995. Towards standardizations of CMV DNA PCR assays. Scand. J. Infect. Dis. Suppl. 99:16-18.
48. Einsele, H., G. Ehninger, H. Hebart, K. M. Wittkowski, U. Schuler, G. Jahn, P. Mackes, M. Herter, T. Klingebiel, J. Loffler, et al. 1995. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 86:2815-2820.
49. Emanuel, D., J. Peppard, D. Stover, J. Gold, D. Armstrong, and U. Hammerling. 1986. Rapid immunodiagnosis of cytomegalovirus pneumonia by bronchoalveolar lavage using human and murine monoclonal antibodies. Ann. Intern. Med. 104:476-81.
50. Enright, H., R. Haake, D. Weisdorf, N. Ramsay, P. McGlave, J. Kersey, W. Thomas, D. McKenzie, and W. Miller. 1993. Cytomegalovirus pneumonia after bone marrow transplantation. Risk factors and response to therapy. Transplantation 55:1339-1346.
51. Erice, A., C. Crumpacker, W. Britt, W. L. Drew, R. Hillam, S. Kao, J. Kolberg, M. Landry, N. Lurain, J. Manischewitz, M. Nokta, S. Spector, A. Weinberg, B. Yen-Lieberman, D. Brambilla, and P. Reichelderfer. 1996. Quantitation of Cytomegalovirus load in blood fractions of patients with AIDS: a comparative study of different laboratory methods, p. 83, abstr. 166. In 3rd Conference on Retroviruses and Opportunistic Infections.
52. Erice, A., M. A. Holm, M. V. Sanjuan, D. L. Dunn, P. C. Gill, and H. H. Balfour, Jr. 1995. Evaluation of CMV-vue antigenemia assay for rapid detection of cytomegalovirus in mixed-leukocyte blood fractions. J. Clin. Microbiol. 33:1014-1015.
53. Falagas, M., D. R. Snydman, R. Ruthazer, B. G. Werner, J. Griffith, and The Boston Center for Liver Transplantation CMVIG Study Group. 1997. Surveillance of blood, urine, and throat specimens are not valuable for predicting cytomegalovirus disease in liver transplant recipients. Clin. Infect. Dis. 24:824-829.
54. Ferre, F. 1992. Quantitative or semi-quantitative PCR: reality versus myth. PCR Methods Appl. 2:1-9.
55. Flood, J., W. L. Drew, R. Miner, D. Jekic-McMullen, L. P. Shen, J. Kolberg, J. Garvey, S. Follansbee, and M. Posher. 1997. Diagnosis of cytomegalovirus (CMV) polyradiculopathy and documentation of in vivo anti-CMV activity in cerobrospinal fluid using branched DNA amplification and antigen assays. J. Infect. Dis. 176:348-352.
56. Fox, J. C., P. D. Griffiths, and V. C. Emery. 1992. Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J. Gen. Virol. 73:2405-2408.
57. Fox, J. C., I. M. Kidd, P. D. Griffiths, P. Sweny, and V. C. Emery. 1995. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J. Gen. Virol. 76:309-319.
58. Francisci, D., A. Tosti, F. Baldelli, G. Stagni, and S. Pauluzzi. 1997. The Pp65 antigenaemia test as a predictor of cytomegalovirus-induced end-organ disease in patients with AIDS. AIDS 11:1341-1345.
59. Francisci, D., A. Tosti, R. Preziosi, F. Baldelli, G. Stagni, and S. Pauluzzi. 1995. Role of antigenemia assay in the early diagnosis and prediction of human cytomegalovirus organ involvement in AIDS patients. Eur. J. Clin. Microbiol. Infect. Dis. 14:498-503.
60. Freyrauth, F., E. Gennetay, J. Petitjean, G. Eugene, B. Hurault de Ligny, J. P. Ryckelynck, C. Legoff, P. Hazera, and C. Bazin. 1994. Comparison of nested PCR for detection of DNA in plasma with pp65 leukocytic antigenemia procedure for diagnosis of human cytomegalovirus infection. J. Clin. Microbiol. 32:1614-1618.
61. Gerard, J., C. Leport, P. Flandre, N. Houhou, D. Salmon-Ceron, J. M. Pepin, C. Mandet, F. Brun-Vezinet, and J. L. Vilde. 1997. Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24:836-840.
62. Gerna, G., F. Baldanti, A. Sarasini, M. Furione, E. Percivalle, M, G. Revello, D. Zipeto, and D. Zella. 1994. Effect of foscarnet induction treatment on quantitation of human cytomegalovirus (HCMV) DNA in peripheral blood polymorphonuclear leukocytes and aqueous humor of AIDS patients with HCMV retinitis. The Italian Foscarnet Study Group. Antimicrob. Agents Chemother. 38:38-44.
63. Gerna, G., M. Furione, F. Baldanti, E. Percivalle, P. Comoli, and F. Locatelli. 1995. Quantitation of human cytomegalovirus DNA in bone marrow transplant recipients. Br. J. Haematol. 91:674-683.
64. Gerna, G., M. Furione, F. Baldanti, and A. Sarasini. 1994. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J. Clin. Microbiol. 32:2709-2717.
65. Gerna, G., M. Parea, E. Percivalle, D. Zipeto, E. Silini, G. Barbarini, and G. Milanesi. 1990. Human cytomegalovirus viraemia in HIV-1-seropositive patients at various clinical stages of infection. AIDS 4:1027-1031.
66. Gerna, G., M. G. Revello, E. Percivalle, and F. Morini. 1992. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J. Clin. Microbiol. 30:1232-1237.
67. Gerna, G., M. G. Revello, E. Percivalle, M. Zavattoni, M. Parea, and M. Battaglia. 1990. Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins. J. Clin. Microbiol. 28: 2681-2688.
68. Gerna, G., A. Sarasini, F. Baldanti, E. Percivalle, D. Zella, M. G. Revello, O. L. Sacco, M. Moroni, A. Darminio, S. Antinori, F. Milazzo, M. Coen, A. Cargnel, A. Fasan, G. P. Carosi, F. Castelli, L. Tommasoni, F. Alberici, P. Viale, P. Cadrobbi, P. Crivellaro, G. Carnevale, A. Pan, F. Suter, G. Marchetti, et al. 1997. Quantitative systemic and local evaluation of the antiviral effect of ganciclovir and foscarnet induction treatment on human cytomegalovirus gastrointestinal disease of patients with AIDS. Antiviral Res. 34: 39-50.
69. Gerna, G., D. Zipeto, M. Parea, M. G. Revello, E. Silini, E. Percivalle, M. Zavattoni, P. Grossi, and G. Milanesi. 1991. Monitoring of human cytomegalovirus infections and ganciclovir treatment in heart transplant recipients by determination of viremia, antigenemia, and DNAemia. J. Infect. Dis. 164:488-498.
70. Gerna, G., D. Zipeto, E. Percivalle, M. Parea, M. G. Revello, R. Maccario, G. Peri, and G. Milanesi. 1992. Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients. J. Infect. Dis. 166: 1236-1244.
71. Ghisetti, V., A. Barbui, M. P. Rocci, E. Donegani, M. Bobbio, A. Pucci, C. Papandrea, S. Pansini, G. Zattera, F. Mollo, M. Di Summa, and G. Marchiaro. 1996. Detection of human cytomegalovirus myocardial involvement by polymerase chain reaction during systemic infection and correlation with pp65 antigenemia and DNAemia in infected heart recipients. Transplantation 61:1072-1075.
72. Gilbert, C., J. Handheld, E. Toma, R. Lalonde, M. G. Bergeron, and G. Boivin. 1998. Emergence and prevalence of cytomegalovirus UI97 mutations associated with ganciclovir resistance in AIDS patients. AIDS 12:125-129.
73. Gilliland, G., S. Perrin, K. Blancbard, and H. F. Bunn. 1990. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:2725-2729.
74. Gondo, H., T. Minematsu, M. Harada, K. Akashi, S. Hayashi, S. Taniguchi, K. Yamasaki, T. Shibuya, Y. Takamatsu, T. Teshima, et al. 1994. Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation. Br. J. Haematol. 86:130-137.
75. Goodrich, J. M., R. A. Bowden, L. Fisher, C. Keller, G. Schoch, and J. D. Meyers. 1993. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann. Intern. Med. 118:173-178.
76. Goodrich, J. M., M. Mon, C. A. Gleaves, C. Du Mond, M. Cays, D. F. Ebeling, W. C. Buhles, B. DeArmond, and J. D. Meyers. 1991. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplant. N. Engl. J. Med. 325:1601-1607.
77. Gor, D., C. Sabin, H. G. Prentice, N. Yyas, S. Man, P. D. Griffith, and V. C. Emery. 1998. Longitudinal fluctuation in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/ recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transplant. 21:597-605.
78. Grefte, A., M. C. Harmsen, M. van der Giessen, S. Knollema, W. J. van Son, and T. H. The. 1994. Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. J. Gen. Virol. 75:1989-1998.
79. Grefte, A., M. van der Giessen, W. van Son, and T. H. The. 1993. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. J. Infect. Dis. 167:270-277.
80. Grefte, J. M., B. T. van der Gun, S. Schmolke, M. van der Giessen, W. J. van Son, B. Plachter, G. Jahn, and T. H. The. 1992. Cytomegalovirus antigenemia assay: identification of the viral antigen as the lower matrix protein pp65. J. Infect. Dis. 166:683-684. (Letter.)
81. Grefte, J. M., B. T. van der Gun, S. Schmolke, M. van der Giessen, W. J. van Son, B. Plachter, G. Jahn, and T. H. The. 1992. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J. Gen. Virol. 73: 2923-2932.
82. Grossi, P., S. Kusne, C. Rinaldo, K. St George, M. Magnone, J. Rakela, J. Fung, and T. E. Starzl. 1996. Guidance of ganciclovir therapy with pp65 antigenemia in cytomegalovirus-free recipients of livers from seropositive donors. Transplantation 61:1659-1660.
83. Grossi, P., L. Minoli, E. Percivalle, W. Irish, M. Vigano, and G. Gerna. 1995. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 59:847-851.
84. Grundy, J. E., A. Ehrnst. H. Einsele, V. C. Emery, H. Hebart, H. G. Prentice, and P. Ljungman. 1996. A three-center European external quality control study of PCR for detection of cytomegalovirus DNA in blood. J. Clin. Microbiol. 34:1166-1170.
85. Halwachs, G., R. Zach, H. Pogglitsch, H. Holzer, A. Tiran, F. Iberer, A. Wasler, H. P. Tscheliessnigg, G. Lanzer, B. Folsch, et al. 1993. A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice. Transplantation 56:338-342.
86. Hansen, K. K., A. Ricksten, B. Hofmann, B. Norrild, S. Olofsson, and L. Mathiesen. 1994. Detection of cytomegalovirus DNA in serum correlates with clinical cytomegalovirus retinitis in AIDS. J. Infect. Dis. 170:1271-1274.
87. Hebart, H., C. Müller, J. Löffler, G. Jahn, and H. Einsele. 1996. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation. Bone Marrow Transplant. 17:861-868.
88. Higuchi, R., G. Dollinger, P. S. Walsh, and R. Griffith. 1992. Simultaneous amplification and detection of specific DNA sequences. Bio/Technology 10:413-417.
89. Higuchi, R., C. Fockler, G. Dollinger, and R. Watson. 1993. Kinetic PCR analysis: real-time monitoring of DNA amplification reactions. Bio/Technology 11:1026-1030.
90. Hiyoshi, M., S. Tagawa, T. Takubo, K. Tanaka, T. Nakao, Y. Higeno, K. Tamura, M. Shimaoka, A. Fujii, M. Higashihata, Y. Yasui, T. Kim, A. Hiraoka, and N. Tatsumi. 1997. Evaluation of the Amplicor CMV test for direct detection of cytomegalovirus in plasma specimens. J. Clin. Microbiol. 35:2692-2694.
91. Ho, S. K. N., C.-Y. Lo, I. K. P. Cheng, and T.-M. Chan. 1998. Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining. J. Clin. Microbiol. 36:638-640.
92. Imbertmarcille, B. M., D. Cantarovich, V. Ferreaubineau, B. Richet, J. P. Soulillou, and S. Billaudel. 1997. Usefulness of DNA viral load quantification for cytomegalovirus disease monitoring in renal and pancreas/renal transplant recipients. Transplantation 63:1476-1481.
93. Imbertmarcille, B. M., N. Robillard, A. S. Poirier, M. Costeburel, D. Cantarovich, N. Milpied, and S. Billaudel. 1997. Development of a method for direct quantification of cytomegalovirus antigenemia by flow cytometry. J. Clin. Microbiol. 35:2665-2669.
94. Jacobson, M. A., M. Zegans, P. R. Pavan, O. D. JJ, F. Sattler, N. Rao, S. Owens, and R. Pollard. 1997. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1443-1445.
95. Jiwa, N. M., W. E. Mesker, J. J. Ploem-Zaaijer, W. van Dorp, T. H. The, and A. K. Raap. 1994. Quantification of low frequency white blood cells expressing human cytomegalovirus antigen by image cytometry. Cytometry 16:69-73.
96. Jiwa, N. M., F. M. van de Rijke, A. Mulder, W. van der Bij, T. H. The, P. H. Rothbarth, J. Velzing, M. van der Ploeg, and A. K. Raap. 1989. An improved immunocytochemical method for the detection of human cytomegalovirus antigens in peripheral blood leucocytes. Histochemistry 91:345-349.
97. Kolberg, J. Personal communication.
98. Kolberg, J., R. Miner, B. Hoo, R. Kelso, J. Wiegand, D. Jekicmcmullen, and W. L. Drew. 1996. Development of a branched DNA signal amplification assay to monitor patients on anti-CMV therapies. Biologicals 24:216.
99. Koskinen, P. K., L. A. Krogerus, M. S. Nieminen, S. P. Mattila, P. J. Hayry, and I. T. Lautenschlager. 1994. Cytomegalovirus infection-associated generalized immune activation in heart allograft recipients: a study of cellular events in peripheral blood and endomyocardial biopsy specimens. Transplant Int. 7:163-71.
100. Krajden, M., P. Shankaran, C. Bourke, and W. Lau. 1996. Detection of cytomegalovirus in blood donors by PCR using the digene SHARP signal system assay: effects of sample preparation and detection methodology. J. Clin. Microbiol. 34:29-33.
101. Kühn, J. E., T. Wendland, H. J. Eggers, E. Lorentzen, U. Wieland, B. Eing, M. Kiessling, and P. Gass. 1995. Quantitation of human cytomegalovirus genomes in the brain of AIDS patients. J. Med. Virol. 47:70-82.
102. Kühn, J. E., T. Wendland, P. Schäfer, K. Möhring, U. Wieland, M. Elgas, and H. J. Eggers. 1994. Monitoring of renal allograft recipients by quantitation of human cytomegalovirus genomes in peripheral blood leukocytes. J. Med. Virol. 44:398-405.
103. Lalezari, J. P., W. L. Drew, E. Glutzer, C. James, D. Miner, J. Flaherty, P. E. Fisher, K. Cundy, J. Hannigan, J. C. Martin, and et al. 1995. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propy1]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J. Infect. Dis. 171:788-796.
104. Landry, M. L., S. Cohen, and K. Huber. 1997. Comparison of EDTA and acid-citrate-dextrose collection tubes for detection of cytomegalovirus antigenemia and infectivity in leukocytes before and after storage. J. Clin. Microbiol. 35:305-306.
105. Landry, M. L., and D. Ferguson. 1993. Comparison of quantitative cytomegalovirus antigenemia assay with culture methods and correlation with clinical disease. J. Clin. Microbiol. 31:2851-2856.
106. Lazzarotto, T., B. Campisi, P. Dalmonte, S. Galli, P. Spezzacatena, P. Guglielmi, and M. P. Landini. 1996. A quantitative test (HCMV-Hybrid-Capture(TM)) to detect human cytomegalovirus DNA in the blood of immunocompromiscd patients compared with antigenemia and polymerase chain reaction. Microbiologica 19:193-201.
107. Reference deleted.
108. Li, C. R., P. D. Greenberg, M. J. Gilbert, J. M. Goodrich, and S. R. Riddell. 1994. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83:1971-1979.
109. Limaye, A., R. A. Bowden, D. Myerson, and M. Boeckh. 1997. Cytomegalovirus disease before engraftment in marrow transplant patients. Clin. Infect. Dis. 24:830-835.
110. Ljungman, P., and P. Griffith. 1993. Definitions of cytomegalovirus infection and disease, p. 233-237. In S. Michelson and S. A. Plotkin (ed.), Multidisciplinary approach to understanding cytomegalovirus disease. Excerpta Medica, Amsterdam, The Netherlands.
111. Ljungman, P., K. Lore, J. Aschan, S. Klaesson, I. Lewensohn-Fuchs, B. Lonnqvist, O. Ringden, J. Winiarski, and A. Ehrnst. 1996. Use of a semiquantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients. Bone Marrow Transplant. 17:583-587.
112. Locatelli, F., E. Percivalle, P. Comoli, R. Maccario, M. Zecca, G. Giorgiani, P. De Stefano, and G. Gerna. 1994. Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome. Br. J. Haematol. 88:64-71.
113. Lu, W., and J. M. Andrieu. 1993. Early identification of human immunodeficiency virus-infected asymptomatic subjects susceptible to zidovudine by quantitative viral coculture and reverse transcription-linked polymerase chain reaction. J. Infect. Dis. 167:1014-1020.
114. Macartney, M., E. J. Gane, B. Portmann, and R. Williams. 1997. Comparison of a new quantitative cytomegalovirus DNA assay with other detection methods. Transplantation 63:1803-1807.
115. Mazzulli, T., S. Wood, R. Chua, and S. Walmsley. 1996. Evaluation of the Digene Hybrid Capture System for detection and quantisation of human cytomegalovirus viremia in human immunodeficiency virus-infected patients. J. Clin. Microbiol. 34:2959-2962.
116. Mendez, J. C., M. J. Espy, T. F. Smith, J. A. Wilson, and C. V. Paya. 1998. Evaluation of PCR primers for early diagnosis of cytomegalovirus infection following liver-transplantation. J. Clin. Microbiol. 36:526-530.
117. Meyers, J. D., P. Ljungman, and L. D. Fisher. 1990. Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia, J. Infect. Dis. 162:373-380.
118. Mitchell, S. 1996. Diagnostic assays in cytomegalovirus retinitis. Br. J. Ophthalmol. 80:195-196. (Editorial.)
119. Murphy, L. D., C. E. Herzog, J. B. Rudick, A. T. Fojo, and S. E. Bates. 1990. Use of the polymerase chain reaction in the quantitation of mdr-1 gene expression. Biochemistry 29:10351-10356.
120. Mutimer, D., A. Matyi-Toth, J. Shaw, E. Elias, K. O'Donnell, and P. Stalhandske. 1997. Patterns of viremia in liver transplant recipients with symptomatic cytomegalovirus infection. Transplantation 63:68-73.
121. Myerow, S., M. Lee, J. Arruda, L. P. Shen, R. Madej, M. Collins, R. Mlner, W. L. Drew, and J. Kolberg. 1997. Development of a branched DNA assay with improved sensitivity for monitoring CMV viral load in immunocompromised patients. Presented at the 13th Annual Clinical Virology Symposium, Clearwater, Fla.
122. Niubo, J., J. L. Perez, J. T. Martinez-Lacasa, A. Garcia, J. Roca, J. Fabregat, S. Gil-Vernet, and R. Martin. 1996. Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients. Diagn. Microbiol. Infect. Dis. 24:19-24.
123. Nolte, F. S., R. K, Emmens, C. Thurmond, P. S. Mitchell, C. Pascuzzi, S. M. Devine, R. Saral, and J. R. Wingard. 1995. Early detection of human cytomegalovirus viremia in bone marrow transplant recipients by DNA amplification. J. Clin. Microbiol. 33:1263-1266.
124. Noonan, K. E., C. Beck, T. A. Holzmayer, J. E. Chin, J. S. Wunder, I. L. Andrulis, A. F. Gazdar, C. L. Willman, B. Griffith, D. D. Von Hoff, et al. 1990. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA 87:7160-7164.
125. Patel, R., T. F. Smith, M. Espy, D. Portela, R. H. Wiesner, R. A. Krom, and C. V. Paya. 1995. A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J. Infect. Dis. 171:1010-1014.
126. Patel, R., T. F. Smith, M. Espy, R. H. Wiesner, R. A. Krom, D. Portela, and C. V. Paya. 1994. Detection of cytomegalovirus DNA in sera of liver transplant recipients. J. Clin. Microbiol. 32:1431-1434.
127. Payan, C., N. Veal, L. Sarol, M. Villarme, C. Ngohou, P. Riberi, S. Francois, N. Ifrah, J. Loison, J. M. Chennebault, E. Pichard, S. Kouyoumdjian, and F. Lunel. 1997. Human cytomegalovirus DNA kinetics using a novel HCMV DNA quantitative assay in white blood cells of immunocompromised patients under ganciclovir therapy. J. Virol. Methods 65:131-138.
128. Percivalle, E., M. G. Revellu, L. Vago, F. Morini, and G. Gerna. 1993. Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement. J. Clin. Invest. 92:663-670.
129. Perez, J. L., M. De Ona, J. Niubo, H. Villar, S. Melon, A. Garcia, and R. Martin. 1995. Comparison of several fixation methods for cytomegalovirus antigenemia assay. J. Clin. Microbiol. 33:1646-1649.
130. Podzamczer, D., E. Ferrer, A. Garcia, J. M. Ramon, J. Niubo, M. Santin, G. Rufi, J. L. Perez, R. Martin, and F. Gudiol. 1997. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients. Scand. J. Infect. Dis. 29:223-227.
131. Poiriertoulemonde, A. S., B. M. Imbertmarcille, V. Ferreaubineau, B. Besse, M. G. Leroux, D. Cantarovich, and S. Billaudel. 1997. Successful quantification of cytomegalovirus DNA by competitive PCR and detection with capillary electrophoresis. Mol. Cell. Probes 11:11-23.
132. Rasmussen, L., S. Morris, D. Zipeto, J. Fessel, R. Wolitz, A. Dowling, and T. C. Merigan. 1995. Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis. J. Infect. Dis. 171:177-182.
133. Rasmussen, L., D. Zipeto, R. A. Wolitz, A. Dowling, B. Efron, and T. C. Merigan. 1997. Risk for retinitis in patients with AIDS can be assessed by quantitation of threshold levels of cytomegalovirus DNA burden in blood. J. Infect. Dis. 176:1146-1155.
134. Reed, E. C., R. A. Bowden, P. S. Dandliker, K. E. Lilleby, and J. D. Meyers. 1988. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann. Intern. Med. 109:783-788.
135. Reid, M. C., M. S. Lachs, and A. R. Feinstein. 1995. Use of methodological standards in diagnostic test research. Getting better but still not good. JAMA 274:645-651.
136. Reusser, P., R. Attenhofer, H. Hebart, C. Helg, B. Chapuis, and H. Einsele. 1997. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplant. Blood 89:3873-3879.
137. Reusser, P., S. R. Riddell, J. D. Meyers, and P. D. Greenberg. 1991. Cytotoxic T-lymphocyte response to cytomegalovirus afler human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 78:1373-1380.
138. Revello, M. G., E. Percivalle, A. Di Matteo, F. Mariai, and G. Gerna. 1992. Nuclear expression of the lower matrix protein of human cytomegalovirus in peripheral blood leukocytes of immunocompromised viraemic patients. J. Gen. Virol. 73:437-442.
139. Revello, M. G., E. Percivalle, A. Sarasini, F. Baldanti, M. Furione, and G. Gerna. 1994. Diagnosis of human cytomegalovirus infection of the nervous system by pp65 detection in polymorphonuclear leukocytes of cerebrospinal fluid from AIDS patients. J. Infect. Dis. 170:1275-1279.
140. Reynes, J., B. Montes, N. Atoui, and M. Segondy. 1996. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients. J. Med. Virol. 49:195-198.
141. Rubin, R. H. 1991. Preemptive therapy in immunocompromised hosts. N. Engl. J. Med. 324:1057-1059.
142. Saltzman, R. L., M. R. Quirk, and M. C. Jordan. 1988. Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J. Clin. Invest. 81:75-81.
143. Saltzman, R. L., M. R. Quirk, and M. C. Jordan. 1992. High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients. J. Clin. Invest. 90:1832-1838.
144. Saltzman, R. L., M. R. Quirk, C. N. Mariash, and M. C. Jordan. 1990. Quantitation of cytomegalovirus DNA by blot hybridization in blood leukocytes of viremic patients. J. Virol. Methods 30:67-77.
145. Salzberger, B., R. A. Bowden, R. Hackman, C. Davis, and M. Boeckh. 1997. Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of CMV disease: risk factors and outcome. Blood 90: 2502-2508.
146. Salzberger, B., C. Franzen, G. Fatkenheuer, O. Cornely, A. Schwenk, H. Rasokat, V. Diehl, and M. Schrappe. 1996. CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients. J. Acquired Immun. Defic. Syndr. Hum. Retrovirol. 11:365-369.
147. Salzberger, B., D. Myerson, and M. Boeckh. 1997. Circulating CMV-infected endothelial cells in marrow transplant patients with CMV disease and CMV infection. J. Infect. Dis. 176:778-781.
148. Schäfer, P., R. W. Braun, K. Möhring, K. Henco, J. Kang, T. Wendland, and J. E. Kühn. 1993. Quantitative determination of human cytomegalovirus target sequences in peripheral blood leukocytes by nested polymerase chain reaction and temperature gradient gel electrophoresis. J. Gen. Virol. 74:2699-2707.
149. Schäfer, P., W. Tenschert, K. Gutensohn, and R. Laufs. 1997. Minimal effect of delayed sample processing on results of quantitative PCR for cytomegalovirus DNA in leukocytes compared to results of an antigenemia assay. J. Clin. Microbiol. 35:741-744.
150. Schmidt, G. M., D. A. Horak, J. C. Niland, S. R. Duncan, S. J. Forman, and J. A. Zaia. 1991. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. The City of Hope-Stanford-Syntex CMV Study Group. N. Engl. J. Med. 324:1005-1111.
151. Schmidt, N. J. 1989. Cell culture procedures for diagnostic virology, p. 78-79. In N. J. Schmidt and R. W. Emmons (ed.), Diagnostic procedures for viral, rickettsial and chlamydial infections, 5th ed. American Public Health Association, Inc., Washington, D.C.
152. Shanley, J. D., E. L. Pesanti, and K. M. Nugent. 1982. The pathogenesis of pneumonitis due to murine cytomegalovirus. J. Infect. Dis. 146:388-396.
153. Shepp, D. H., P. S. Dandliker, P. de Miranda, T. C. Burnette, D. M. Cederberg, L. E. Kirk, and J. D. Meyers. 1985. Activity of 9-[2-hydroxy-1-(hydroxymethy1)ethoxymethy1]guanine in the treatment of cytomegalovirus pneumonia. Ann. Intern. Med. 103:368-373.
154. Shepp, D. H., M. E. Match, A. B. Ashraf, S. M. Lipson, C. Millan, and R. Pergolizzi. 1996. Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS. J. Infect. Dis. 174:184-187.
155. Shibata. M., M. Terashima, H. Kimura, K. Kuzushima, J. Yoshida, K. Horibe, and T. Morishima. 1992. Quantitation of cytomegalovirus DNA in lung tissue of bone marrow transplant recipients. Human Pathology. 23: 911-915.
156. Shinkai, M., S. A. Bozzette, W. Powderly, P. Frame, and S. A. Spector. 1997. Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J. Infect. Dis. 175:302-308.
157. Shinkai, M., and S. A. Spector. 1995. Quantitation of human cytomegalovirus (HCMV) DNA in cerebrospinal fluid by competitive PCR in AIDS patients with different HCMV central nervous system diseases. Scand. J. Infect. Dis. 27:559-561.
158. Slavin, M. A., C. A. Gleaves, H. G. Schoch, and R. A. Bowden. 1992. Quantification of cytomegalovirus in bronchoalveolar lavage fluid after allogeneic marrow transplantation by centrifugation culture. J. Clin. Microbiol. 30:2776-2779.
159. Smith, I. L., M. Shinkai, W. R. Freeman, and S. A. Spector. 1996. Polyra-diculopathy associated with ganciclovir-resistant cytomegalovirus in an AIDS patient: phenotypic and genotypic characterization of sequential virus isolates. J. Infect. Dis. 173:1481-1484.
160. Spector, S. A., G. F. McKinley, J. P. Lalezari, T. Samo, R. Andruczk, S. Follansbee, P. D. Sparti, D. V. Havlir, G. Simpson, W. Buhles, R. Wong, and M. Stempien. 1996. Oral ganciclovir for the prevention of cytomegalovirus disease in persons with AIDS. Roche Cooperative Oral Ganciclovir Study Group. N. Engl. J. Med. 334:1491-1497.
161. Spector, S. A., R. Merrill, D. Wolf, and W. M. Dankner. 1992. Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J. Clin. Microbiol, 30:2359-2365.
162. Spector, S, A., R. Wong, K. Hsia, M. Pilcher, and M. J. Stempien. 1998. Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest. 101:497-502.
163. St. George, K., and C. R. Rinaldo. 1997. Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay. Clin. Diagn. Virol. 7:147-152.
164. Storch, G. A., R. S. Buller, T. C. Bailey, N. A. Ettinger, T. Langlois, M. Gaudreault-Keener, and P. L. Welby. 1994. Comparison of PCR and pp65 antigenemia assay with quantitative shell vial culture for detection of cytomegalovirus in blood leukocytes from solid-organ transplant recipients. J. Clin. Microbiol. 32:997-1003.
165. Storch, G. A., N. A. Ettinger, D. Ockner, M. R. Wick, M. Gaudreault-Keener, J. Rossiter, E. P. Trulock, and J. D. Cooper. 1993. Quantitative cultures of the cell fraction and supernatant of bronchoalveolar lavage fluid for the diagnosis of cytomegalovirus pneumonitis in lung transplant recipients. J. Infect. Dis. 168:1502-6.
166. Storch, G. A., M. Gaudreault-Keener, and P. C. Welby. 1994. Comparison of heparin and EDTA transport tubes for detection of cytomegalovirus in leukocytes by shell vial assay, pp65 antigenemia assay, and PCR. J. Clin. Microbiol. 32:2581-2583.
167. Tevere, V. Personal communication.
168. The, T. H., A. P. van den Berg, M. C. Harmsen, W. van der Bij, and W. J. van Son. 1995. The cytomegalovirus antigenemia assay: a plea for standardization. Scand. J. Infect. Dis. Suppl. 99:25-29.
169. The, T. H., M. van der Ploeg, A. P. van den Berg, A. M. Vlieger, M. van der Giessen, and W. J. van Son. 1992. Direct detection of cytomegalovirus in peripheral blood leukocytes - a review of the antigenemia assay and polymerase chain reaction. Transplantation 54:193-198.
170. Toyoda, M., J. B. Carlos, O. A. Galera, K. Galfayan, X. M. Zhang, Z. L. Sun, L. S. C. Czer, and S. C. Jordan. 1997. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients. Transplantation 63:957-963.
171. Van den Berg, A. Personal communication.
172. van den Berg, A. P., I. J. Klompmaker, E. B. Haagsma, A. Scholten-Sampson. C. M. Bijleveld, J. Schirm, M. van der Giessen, M. J. Slooff, and T. H. The. 1991. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J. Infect. Dis. 164:265-270.
173. van den Berg, A. P., A. M. Tegzess, A. Scholten-Sampson, J. Schirm, M. van der Giessen, T. H. The, and W. J. van Son. 1992. Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation. Transplant Int. 5:101-106.
174. van den Berg, A. P., W. van der Bij, W. J. van Son, J. Anema, M. van der Giessen, J. Schirm, A. M. Tegzess, and T. H. The. 1989. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation - a report of 130 consecutive patients. Transplantation 48:991-995.
175. van den Berg, A. P., W. J. van Son, E. B. Haagsma, I. J. Klompmaker, A. M. Tegzess, J. Schirm, G. Dijkstra, M. van der Giessen, M. J. Slooff, and T. H. The. 1993. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation 55: 847-851.
176. van der Bij, W., J. Schirm, R. Torensma, W. J. van Son, A. M. Tegzess, and T. H. The. 1988. Comparison between viremia and antigenemia for detection of cytomegalovirus in blood. J. Clin. Microbiol. 26:2531-2535.
177. van der Bij, W., R. Torensma, W. J. van Son, J. Anema, J. Schirm, A. M. Tegzess, and T. H. The. 1988. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes. J. Med. Virol. 25:179-188.
178. Veal, N., C. Payan, D. Fray, L. Sarol, O. Blanchet, S. Kouyoumdjian, and F. Lunel. 1996. Novel DNA assay for cytomegalovirus detection: comparison with conventional culture and pp65 antigenemia assay. J. Clin. Microbiol. 34:3097-3100.
179. Vlieger, A. M., G. J. Boland, N. M. Jiwa, R. A. de Weger, R. Willemze, G. C. de Gast, and J. H. Falkenburg. 1992. Cytomegalovirus antigenemia assay or PCR can be used to monitor ganciclovir treatment in bone marrow transplant recipients. Bone Marrow Transplant. 9:247-253.
180. Vogel, J. U., J. Cinatl, A. Lux, B. Weber, A. J. Driesel, and H. W. Doerr. 1996. New PCR assay for rapid and quantitative detection of human cytomegalovirus in cerebrospinal fluid. J. Clin. Microbiol. 34:482-483.
181. Wade, J. C., R. W. McGuffin, S. C. Springmeyer, B. Newton, J. W. Singer, and J. D. Meyers. 1983. Treatment of cytomegaloviral pneumonia with high-dose acyclovir and human leukocyte Interferon. J. Infect. Dis. 148: 557-562.
182. Wentworth, B. B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258.
183. Wetherill, P. E., M. L. Landry, P. Alcabes, and G. Friedland. 1996. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 12:33-37.
184. Zaia, J. A., G. M. Gallez-Hawkins, B. R. Tegtmeier, A. ter Veer, X. Li, J. C, Niland, and S. J. Forman. 1997. Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. J. Infect. Dis. 176:782-785.
185. Zipeto, D., F. Baldanti, D. Zella, M. Furione, A. Cavicchini, G. Milanesi, and G. Gerna. 1993. Quantification of human cytomegalovirus DNA in peripheral blood polymorphonuclear leukocytes of immunocompromised patients by the polymerase chain reaction. J. Virol. Methods 44:45-55.
186. Zipeto, D., S. Morris, C. Hong, A. Dowling, R. Wolitz, T. C. Merigan, and L. Rasmussen. 1995. Human cytomegalovirus (CMV) DNA in plasma reflects the quantity of CMV DNA present in leukocytes. J. Clin. Microbiol. 33:2607-2611.
187. Zipeto, D., M. G. Revello, E. Silini, M. Parea, E. Percivalle, M. Zavattoni, G. Milanesi, and G. Gerna. 1992. Development and clinical significance of a diagnostic assay based on the polymerase chain reaction for detection of human cytomegalovirus DNA in blood samples from immunocompromised patients. J. Clin. Microbiol. 30:527-530.
188. Zurlo, J. J., D. O'Neill, M. A. Polis, J, Manischewitz, R. Yarchoan, M. Baseler, H. C. Lane, and H. Masur. 1993. Lack of clinical utility of cytomegalovirus blood and urine cultures in patients with HIV infection. Ann. Intern. Med. 118:12-17.